Accelerated recovery using magnesium ibogaine: characterizing the subjective experience of its rapid healing from neuropsychiatric disorders. [PDF]
Olash C +8 more
europepmc +1 more source
Adverse outcomes following psychedelic use in adolescents and adults: associations with age and personality traits. [PDF]
Sjöström D +2 more
europepmc +1 more source
Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants. [PDF]
Arikci D +10 more
europepmc +1 more source
Effects of a Single Sub-Anesthetic Dose of Ketamine in Tobacco Use Disorder: An Active-Placebo, Randomized Crossover Study. [PDF]
Luzum NR +7 more
europepmc +1 more source
From Science to Pleasure: Justifications of the Use of Classic Psychedelics in Finland. [PDF]
Tsupari M, Hupli A.
europepmc +1 more source
Magical Thinking and Mystical Experience: An Exploration of Delusional Disorder in Schizophrenic Patients. [PDF]
Pratiwi A +6 more
europepmc +1 more source
Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD). [PDF]
Skalski P +3 more
europepmc +1 more source
Psychedelic-Assisted Interventions in Palliative Care: A Narrative Overview and Critical Evaluation. [PDF]
Soares DA, Campolina AG.
europepmc +1 more source
Oceanic states of consciousness-an existential-neuroscience perspective. [PDF]
Unterrainer HF.
europepmc +1 more source
Evaluation of Current Evidence on the Efficacy of Esketamine in Treating Substance-Use Disorders in Patients With Treatment-Resistant Depression (TRD): A Narrative Review. [PDF]
Shelke S, Thummalapally RR.
europepmc +1 more source

